Forschungsdatenbank

Ansicht
Sortiert
Hennermann Julia
A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase in Adolescent Subjects (Ages 12-17) with Phenylketonuria Featuring an Open-Label Randomized Two-Arm (Active vs Diet-Only Control) Design
Projekt 2022-2028
Hennermann Julia
A PHASE III STUDY OF JR-141 IN MUCOPOLYSACCHARIDOSIS TYPE II (HUNTER SYNDROME) PATIENTS
Projekt 2022-2025
Hennermann Julia
SHP675-301: A Phase 3, Open-label Study to Evaluate the Efficacy and Safety of REPLAGAL® in Treatment-naïve Subjects with Fabry Disease
Projekt 2021-2025
Hennermann Julia
A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of VTS-270 (2-hydroxypropyl-β-cyclodextrin) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease
Projekt 2018-2025
Hennermann Julia
A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of Avalglucosidase Alfa (neoGAA, GZ402666) and Alglucosidase Alfa in Treatment naïve Patients With Late-onset Pompe Disease
Projekt 2018-2025
Sortiert
Laufs V., Hasenburg A., Busch M. A., Lang F., Macchiella D., Mildenberger E., Seidmann L., Hennermann J. B.
Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia
JIMD REPORTS. 2025; 66(4). Article
Datensatz in Web of Science®
Mengel Eugen, Da Riol Rosalia M., Del Toro Mireia, Deodato Federica, Gautschi Matthias, Grunewald Stephanie, Gronborg Sabine Weller, Harmatz Paul, Hennermann Julia B., Heron Benedicte, Maier Esther M., Santra Saikat, Sharma Reena, Tylki-Szymanska Anna, Cording Malene, Himmelstrup Louise, Guenther Sven, Dali ?
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial
MOLECULAR GENETICS AND METABOLISM. 2025; 145(4). Article
Datensatz in Web of Science®
Mengel Eugen, Patterson Marc C., Da Riol Rosalia M., Del Toro Mireia, Deodato Federica, Gautschi Matthias, Grunewald Stephanie, Gronborg Sabine Weller, Harmatz Paul, Hennermann Julia B., Heronk Benedicte, Maier Esther M., Roubertie Agathe, Santra Saikat, Tylki-Szymanska Anna, LaGorio Lisa, Berry-Kravis Elizabeth, Porter Forbes D., Solomon Beth, Himmelstrup Louise, Mickle Travis, Guenther Sven, Dali Christine i
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale
MOLECULAR GENETICS AND METABOLISM REPORTS. 2025; 43. Article
Datensatz in Web of Science®
Mistry Pramod K., Carwile Jenny L., Burrow Andrew, Ganesh Jaya, Camelo Jr Jose Simon, Hennermann Julia B., Batista Julie L., Oliveira-dos-Santos Antonio, Perichon Maria G., Tantawy Azza
Long-term outcomes of imiglucerase treatment in children withGaucher disease type 1 or type 3 starting therapy before the age of2 years
MOLECULAR GENETICS AND METABOLISM. 2025; 144(2). Meeting Abstract
Datensatz in Web of Science®
Muetze Ulrike, Stengel Julia, Gleich Florian, Kessler Svenja, Gruenert Sarah C., Thimm Eva, Hennermann Julia B., Freisinger Peter, Kraemer Johannes, Schnabel-Besson Elena, Mengler Katharina, Shtylla Alboren, Morath Marina, Hoffmann Georg F., Garbade Sven, Koelker Stefan
Long-Term Outcomes of Adolescents and Young Adults Identified by Metabolic Newborn Screening
PEDIATRICS. 2025; 155(4). Article
Datensatz in Web of Science®
Hennermann Julia B.
Treatment of mucopolysaccharidoses
Vortrag 2014